About Sindh Infectious Diseases Hospital & Research Center
Sindh Infectious Diseases Hospital & Research Centre (SIDH & RC) was established in response to the global COVID-19 pandemic in 2020. This hospital, located in Karachi and affiliated with Dow University of Health Sciences, stands as Pakistan’s first dedicated infectious diseases facility. Led by the dynamic Prof. Mohammed Saeed Quraishy, Vice Chancellor of Dow University, our incredible team overcame numerous challenges to swiftly create a specialized space for COVID patients.
With intensive training, our healthcare professionals ensure quality care, extending services beyond COVID to areas like pediatrics, pulmonology, critical care, nephrology, and neurology. SIDH not only responds to crises but also symbolizes resilience and collective ability. We express heartfelt gratitude to our team for their support, hard work, and sacrifices, making this milestone possible.
Facilities
As we stand on the cusp of a new era in healthcare delivery, SIDH symbolizes not only a response to a crisis but also a testament to our collective resilience and ability to overcome challenges. I extend my heartfelt gratitude to each member of the SIDH team for their unwavering support, hard work, and sacrifices that made this milestone possible.
Together, let us continue to be the beacons of hope and continue to serve our community with dedication and compassion, knowing that our efforts contribute to the greater well-being of society and Pakistan.
| # | Facilities |
|---|---|
| 1 | Sindh Infectious Diseases Hospital & Research Centre (SIDH & RC) is a 175-bedded government hospital. |
| 2 | It houses adult units with 48 ICU beds and 68 HDU beds, along with pediatric units having 8 PICU beds and 34 HDU beds. |
| 3 | Since its inception, SIDH & RC has provided high-quality, free-of-cost patient care to over 40,000 individuals. |
| 4 | The hospital has managed 16,000 inpatient cases and over 27,000 outpatient cases to date. |
| 5 | During the COVID-19 pandemic, SIDH & RC was the exclusive hospital in Karachi equipped with 48 ICU beds and 110 HDU beds for critical and severe COVID cases. |
| 6 | Despite restrictions, the hospital offered a unique 2-hour counseling session, addressing concerns and fears of attendants and patients' families. |
| 7 | SIDH & RC has expanded its services to cover infectious diseases, pulmonology, nephrology, neurology, and pediatric infectious diseases. |
| 8 | Challenging cases such as HIV/AIDS, Diphtheria, Tuberculosis, and Crimean Congo Hemorrhagic Fever (CCHF) are managed. |
| 9 | The hospital maintains twelve isolation rooms with negative pressure to implement airborne precautions, ensuring the prevention of contagious diseases. |
| 10 | Pulmonology services include managing obstructive and restrictive airway diseases, connective tissue diseases, empyema, pneumothorax, and occupational pulmonary diseases. |
| 11 | Skillful pulmonology consultants perform procedures like tube thoracotomy and therapeutic thoracentesis. |
| 12 | In-house ICU consultants are available 24/7, addressing critical patient issues and performing emergency procedures such as intubation and CVP/DL/A-lines insertion. |
| 13 | The Pediatric Unit for Infectious Diseases is distinctive in the city, dealing with challenging pediatric cases. |
| 14 | Daily triage and a pediatric clinic help identify critical cases and provide timely treatment. |
| 15 | To offer holistic treatment, SIDH has radiology, pharmacy, nutrition, physiotherapy, hemodialysis, and laboratory services |
| 16 | A rehabilitation center has recently been inaugurated to cater to patients with post-COVID pulmonary fibrosis and other diseases requiring rehabilitation. |
| 17 | SIDH has initiated an HIV Treatment Centre offering free HIV testing and treatment through the national program. |
| 18 | The hospital actively contributes to research projects and international multi-center clinical trials, aiming to find novel solutions to local healthcare problems and advance healthcare approaches. |
| 19 | SIDH & RC's Clinical Trial Unit, approved by DRAP for phase I-IV trials, has successfully completed multicenter international trials, with more in the pipeline. |
Contact Us
Sindh Infectious Diseases Hospital & Research Center